A drug commonly used in treatment for urinary tract infections may carry a risk of cancer, according to a recent study.

As retailers begin to showcase items for early back-to-school shopping, chemicals, and waste watchdog BAN Toxics warns ...

Popular over-the-counter drugs used to treat uncomfortable urinary tract infections may come with a potential cancer risk.

From the editorial: "Some 17,000 pharmacies nationwide — including 20 in Duluth, Superior, Hermantown, and Two Harbors — are now authorized as year-round collection locations." ...

GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...

A growing body of research is raising concerns about the potential for certain popular dietary supplements, often perceived ...

Tweaking the pirfenidone molecule yields an evidently effective but less toxic antifibrotic drug, investigators say.

Which of the thousands of sunscreens on store shelves deliver the safest, most effective protection for your family? Here’s ...

There are two soup recalls to know about right now. First, ready-to-eat chicken soups are being recalled, according to the ...

Healthcare workers identify 19 dangerous everyday habits including driving tired, medication errors, dental neglect and home ...

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...